Evaluation of SARS-CoV-2 Humoral Response Following Vaccination with ChAdOx1 nCoV-19 and/or Sinopharm, BBIBP-CorV: Correspondence.

Q3 Medicine

Journal of Nepal Health Research Council Pub Date : 2024-06-22 DOI:10.33314/jnhrc.v22i01.5138

Hinpetch Daungsupawong, Viroj Wiwanitkit

引用次数: 0

Abstract

n/a.

查看原文本刊更多论文

接种 ChAdOx1 nCoV-19 和/或国药集团 BBIBP-CorV 疫苗后的 SARS-CoV-2 体液反应评估：通信。

不适用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Nepal Health Research Council Medicine-Medicine (all)

CiteScore

1.40

自引率

0.00%

发文量

审稿时长

15 weeks

期刊介绍： The journal publishes articles related to researches done in the field of biomedical sciences related to all the discipline of the medical sciences, medical education, public health, health care management, including ethical and social issues pertaining to health. The journal gives preference to clinically oriented studies over experimental and animal studies. The Journal would publish peer-reviewed original research papers, case reports, systematic reviews and meta-analysis. Editorial, Guest Editorial, Viewpoint and letter to the editor are solicited by the editorial board. Frequently Asked Questions (FAQ) regarding manuscript submission and processing at JNHRC.